You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
食卫局:暂未收到阿斯利康就认可其新冠疫苗申请
阿思达克 04-07 10:39
本地传媒引述食物及卫生局表示,任何疫苗供应本港及为市民接种前,必须先经过相关规例的程序批准认可作紧急使用,卫生署至今未收到阿斯利康(AZN.US)就认可其新冠疫苗提交的申请,期间将密切注意其他药物监管当局公布的最新资料,并会继续与药厂联络,索取相关使用安全资料。当局并重申,政府会在确保疫苗符合安全、效能和质素的要求,以及按照相关规定批准作紧急使用後,方会安排市民接种。

外电早前报道,欧洲药品管理局一名高层指阿斯利康研发的新型冠状病毒疫苗与血栓明显存在联系。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account